| 标题 |
Efficacy and safety of camrelizumab plus docetaxel and carboplatin as neoadjuvant therapy for stage II-III triple-negative breast cancer: the HELEN-Trio 011 randomized clinical trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Ann Oncol 作者:Jiao D, Sun X, Qiao J, Jia H, Liu X, Dai H, Zhang C, Wei Y, Chen B, Sun Y, Yu J, Zou L, Li L, Feng Y, Yan M, Liu L, Wang X, Zhou Y, Lu P, Wang W, Ji F, Jia L, Zhao B, Guo X, Sun Y, Huang T, Wu J, Lü M, Zhu J, Zhang J, Wang J, Yang H, Wang P, Niu L, Pang Z, Xiang Y, Lu Z, Chen X, Wang C, Liu Z 出版日期:2026-10-16 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)